ArticleCureus2025
Morita Therapy for Persistent Postural-Perceptual Dizziness (PPPD): A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistent postural-perceptual dizziness (PPPD) is a chronic functional vestibular disorder that persists for more than three months and significantly impairs patients' mental health and quality of life (QoL). The onset and persistence of PPPD are believed to involve excessive attention to symptoms, requiring approaches from both physical and psychological perspectives. Morita therapy (MT) is a psychotherapy that aims to improve symptoms through defocusing attention from symptoms. This article reports a case in which five sessions of MT were conducted for a PPPD patient who had shown resistance to conventional treatments such as pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) and vestibular rehabilitation (VR). As a result of the intervention, the patient's excessive attention to dizziness symptoms decreased and participation in previously avoided activities was promoted, leading to marked improvements in dizziness symptoms, anxiety, depressive symptoms, and QoL. These effects were maintained at the three-month follow-up after treatment completion. This case suggests that MT could be a promising treatment option for PPPD patients who do not respond to existing treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.